OBJECTIVES: Elevated asymmetric dimethylarginine (ADMA) is associated with an increased risk of coronary artery disease. A prognostic value of ADMA following coronary artery bypass grafting (CABG) is unknown. The aim of the current study was to assess the effect of CABG on ADMA and oxidative stress and determine their associations with postoperative complications.
INTRODUCTION
Decreased bioavailability of nitric oxide (NO) is the main characteristic of endothelial dysfunction [1] . Oxidative stress during myocardial reperfusion after coronary artery bypass grafting (CABG) reduces the bioavailability of NO, thereby removing its cardioprotective effects, including the inhibition of neutrophil accumulation, inactivation of superoxide radicals and improvement of coronary blood flow [2] . A major cause of postoperative myocardial infarction (PMI) and early mortality after CABG is graft failure. During the first month after CABG, venous graft failure results mainly from thrombotic occlusion. This propensity to thrombosis is enhanced by deficient venous endothelial production of NO [3] .
Asymmetric dimethylarginine (ADMA) is a naturally occurring NO synthase inhibitor [4] . The main pathway of ADMA elimination is degradation by dimethylarginine dimethylaminohydrolases (DDAH) . It has been demonstrated that elevated plasma ADMA, observed in atherosclerotic vascular disease, is associated with impaired DDAH activity [5] . Increased plasma ADMA concentrations have also been detected in diabetes, arterial hypertension, renal insufficiency, hyperlipidaemia, hyperhomocysteinaemia and chronic heart failure [6] . The response to cardiopulmonary bypass (CPB), surgical trauma, manipulation of the heart, pericardial suction, heparin, protamine administration and anaesthesia during CABG results in enhanced inflammation and reactive oxygen species (ROS) formation [7] . The biological activity of DDAH is reduced by oxidative stress, leading to ADMA accumulation and blockage of NO synthesis [6, 8] . By inhibiting NO synthase, plasma ADMA may reduce vascular compliance, increase vascular resistance and limit the blood flow [9] .
8-iso-prostaglandin F 2α ) is considered a stable and reliable biomarker of oxidative stress [10] . It has been demonstrated that oxidative stress, measured by 8-iso-PGF 2α , is enhanced in acute coronary syndromes and in ischaemia reperfusion injury [11] .
Elevated plasma ADMA was shown to predict adverse events after non-cardiac surgery [12] . To our knowledge, there have been three studies investigating ADMA formation during and following CABG, and one study correlating ADMA levels with saphenous vein graft disease [13] [14] [15] [16] . However, associations between circulating ADMA and early postoperative outcomes following CABG have not been evaluated. This prompted us to assess the impact of ADMA and oxidative stress on clinical outcomes in the early postoperative period after CABG. Moreover, we sought to investigate the links between plasma ADMA levels and 8-iso-PGF 2α formation in patients undergoing elective CABG.
MATERIALS AND METHODS

Patients
The study population comprised 158 consecutive patients with stable angina who were scheduled for elective, primary, isolated on-pump CABG between January and March 2008. The study was performed in accordance with the Declaration of Helsinki, and all patients provided written informed consent. Indications for CABG were in keeping with the American College of Cardiology and American Heart Association (ACC/AHA) guidelines for CABG [17] . We excluded patients with a history of any cardiac surgery or percutaneous coronary intervention (PCI) within 1 month prior to the enrolment, and those with renal dysfunction (serum creatinine level >177 µmol/l) [18] . Diabetes was defined as a history of diabetes, treatment with hypoglycaemic agents or fasting glycaemia greater than 7 mmol/l. Hypercholesterolaemia was defined as a history of diagnosed and/or treated hypercholesterolaemia, or total cholesterol greater than 5.18 mmol/l [19] .
All data, including the European System for Cardiac Operative Risk Evaluation (EuroSCORE) I, were collected prospectively. The primary end points were PMI and in-hospital cardiovascular death. For patients with myocardial infarction within 24 h after CABG, PMI was defined as the serum creatine kinase-myocardial band (CK-MB) level greater than or equal to five times the upper limit of normal, and new Q waves had to be present or CK-MB value had to be greater than or equal to 10 times the upper limit of normal (with or without Q waves) and no symptoms were required [19] . The upper normal value of CK-MB is 17 U/l. In-hospital cardiovascular death was defined as death due to cardiovascular diseases, occurring during the same hospitalization. CK-MB values were measured at 6, 12, 18 and 24 h after CABG.
Coronary artery bypass grafting procedure
All oral medications were withdrawn 12 h before CABG. All patients underwent standardized anaesthesia, and received standard median sternotomy. Cardiopulmonary bypass was performed at moderate hypothermia (oesophageal temperature, 32°C) using a non-pulsatile roller pump ( Jostra Medizintechnik AG, Hirrlingen, Germany) and a 40-μm arterial blood filter ( Jostra Medizintechnik AG, Hirrlingen, Germany). During CPB, blood flow was maintained at 2.0-2.4 l/min/m 2 , with a mean arterial pressure of 40-60 mmHg. Cardiac arrest was achieved by means of intermittent antegrade warm blood or cold crystalloid cardioplegia, according to surgeon's preference. Anticoagulation was achieved by administration of heparin (500 IU/kg) before the onset of CPB and was monitored by means of the activated clotting time (ACT), which had to be >400 s during CPB. At the end of CPB, anticoagulation was reversed by protamine to a normal ACT. For the left internal mammary artery harvesting, the left pleural space was opened. All procedures were performed by experienced surgeons. After the surgery, the patients were transferred to the intensive care unit (ICU) for postoperative ventilation, and were extubated following standard criteria.
Laboratory investigations
Fasting blood samples were collected from an antecubital vein with minimal stasis on the morning of the CABG day, before the onset of any surgery-related procedures. Postoperatively, fasting venous blood was drawn twice: 18-36 h and 5-7 days after the surgery. Routine laboratory variables were determined using standard laboratory methods. Plasma ADMA concentrations were determined by isocratic high-performance liquid chromatography, as described [20] . Plasma 8-iso-PGF 2α levels were assessed using a commercially available enzyme-linked immunosorbent assay kit (ELISA) (Cayman Chemical, Ann Arbor, MI, USA). All parameters were measured in duplicate by an investigator blinded to the sample origin. All intra-assay and interassay coefficients of variation were below 7%.
Statistical analysis
Descriptive statistic was described as numbers and percentages for categorical variables. Continuous variables were presented as mean [(±standard deviation (SD)] or median and quartiles, as appropriate. To examine the differences between two independent groups, Student's t-test (for continuous normally distributed variables) or Mann-Whitney U-test (for non-normally distributed variables) were used. The χ 2 test or Fisher's exact test were used to compare distributions of categorical variables between independent groups. In order to test the differences between the paired groups while keeping all the data, the generalized least squares testing approach was employed. To assess dependence between continuous variables, Spearman's correlation coefficient was calculated. The strength and direction of an association between PMI or in-hospital death (dependent variables) and independent variables was described by odds ratios (ORs), along with 95% confidence interval (CI), as obtained from logistic regression. No multivariate logistic regression modelling was performed owing to a low number of PMI events (13 cases) and in-hospital death events (6 cases). Statistical analysis was performed with STATISTICA 10.0 (StatSoft, Tulsa, OK, USA). Two-sided P-values of <0.05 were considered statistically significant.
RESULTS
Baseline data
A group of 158 CABG patients, mostly hypercholesterolaemic, hypertensive and overweight men with a history of MI, were studied (Table 1) . Mean baseline ADMA was 0.56 ± SD 0.06 μmol/l and 8-iso-PGF 2α was 359 ± 39.1 pg/ml (Table 2 ). Diabetic patients had higher baseline ADMA (0.57 ± 0.05 μmol/l vs 0.54 ± 0.05 μmol/l for non-diabetics, P = 0.005) and baseline 8-iso-PGF 2α (375 ± 36.3 pg/ml vs 352 ± 35.4 pg/ml, P = 0.0003). We found no associations between baseline ADMA or 8-iso-PGF 2α and age, EuroSCORE I value, body mass index and hypercholesterolaemia (data not shown).
Peri-and postoperative data
All patients were operated on-pump, using warm blood cardioplegia or cold crystalloid cardioplegia. ADMA increased by 68% to 0.94 ± 0.11 μmol/l at 18-36 h after CABG (P = 0.0001) and then decreased by 20% to 0.75 ± 0.12 μmol/l on 5-7 postoperative days (P = 0.0001) ( Table 2) . Similarly, 8-iso-PGF 2α increased by 30% to 467 ± 42.4 pg/ml at 18-36 h post-CABG (P = 0.05), and then decreased by 11% to 417 ± 47.3 pg/ml on 5-7-day-post-CABG (P < 0.0001) ( Table 2 ). There was a positive correlation between ADMA and 8-iso-PGF 2α at all-time points (r = 0.53 at baseline, r = 0.81 at 18-36 h and r = 0.80 on 5-7 postoperative days, P < 0.0001 for all comparisons). There were no correlations between postoperative ADMA or 8-iso-PGF 2α and aortic crossclamp time or CPB duration. No differences, in terms of studied parameters, were noted for different types of cardioplegia.
Postoperative myocardial infarction
Of the 158 patients, 13 (8.2%) patients developed PMI. The mean age of the PMI patients was 63.2 ± 6.5 years, mean EuroSCORE I was 2.6 ± 1.9 points, 3 (23.1%) patients were female and 4 (30.8%) patients had type 2 diabetes. There were no differences in the baseline demographic or clinical variables between the PMI subgroup and remaining subjects (Table 1) . However, patients with PMI had higher ADMA and 8-iso-PGF 2α levels either at the baseline or postoperatively, as compared with the PMI-free group. In PMI patients, ADMA increased postoperatively from 0.63 ± 0.09 μmol/l at baseline to 1.06 ± 0.17 μmol/l at 18-36 h after CABG, and remained at the same level of 1.06 ± 0.09 μmol/l at 5-7 days after operation (P = 0.01, P = 0.019 and P = 0.001, respectively, compared with the patients without PMI; Table 2 and Fig. 1 ). Also, levels of 8-iso-PGF 2α in PMI subjects rose from the baseline value of 389 ± 50 pg/ml to 506 ± 67.5 pg/ml at 18-36 h after CABG, and then increased again to 540 ± 15.5 pg/ml at 5-7 days after surgery. Notably, these levels were also higher than in PMI-free individuals (P = 0.039, P = 0.054 and P < 0.001, respectively, compared with the patients without PMI; Table 2 and Fig. 2 ). Univariate analysis revealed that ADMA and 8-iso-PGF 2α levels, both preoperative and postoperative (except of 8-iso-PGF 2α level at 18-36 h after the surgery), were associated with the risk of PMI (Table 2) . 
In-hospital death
Six patients (3.8%) died during the early postoperative period because of extensive PMI. They did not differ from the remaining subjects with respect to demographic and clinical variables (mean age, 65.7 ± 6.6 years; mean EuroSCORE I, 3.5 ± 2.1 points; all patients were male, and 3 [50%] patients had type 2 diabetes; Table 3 ). As in the case of PMI, this small subgroup was characterized by higher ADMA and 8-iso-PGF 2α levels at all three time points. Baseline ADMA in this subgroup of patients was 0.64 ± 0.1 μmol/l, 1.17 ± 0.16 μmol/l at 18-36 h after CABG and 1.13 ± 0.06 μmol/l at 5-7 days after operation (P = 0.048, P = 0.031 and P = 0.003, respectively, compared with the survivors; Table 4 and Fig. 3 ). In the patients who died after CABG, 8-iso-PGF 2α was 408 ± 48.1 pg/ml at baseline, 545 ± 51.2 pg/ml at 18-36 h after CABG and 538 ± 21.0 pg/ml at 5-7 days after surgery (P = 0.048, P = 0.023 and P = 0.004, respectively, compared with the survivors; Table 4 and Fig 4) . Univariate analysis showed that PMI and higher perioperative values of ADMA, and 8-iso-PGF 2α at all three time points were associated with the risk of early mortality after surgery (Tables 3 and 4) .
DISCUSSION
This study shows that elective on-pump CABG is associated with a marked increase in ADMA, which is accompanied by enhanced oxidative stress in the early postoperative period. Mean baseline ADMA levels, presented by us, were similar to those shown elsewhere [21] . Additionally, we found that plasma ADMA was higher in subjects with type 2 diabetes, which is in line with other reports [22] . We demonstrated for the first time that patients who suffer from PMI (or die because of PMI) early after primary isolated CABG have higher levels of ADMA and 8-iso-PGF 2α , either preoperatively or postoperatively. Importantly, the elevation of plasma ADMA cannot be explained by renal function impairment, as renal dysfunction was used as an exclusion criterion in this study. This novel finding proves that oxidative stress and the disturbance of NO bioavailability are linked with the occurrence of adverse events after cardiac surgery. Our results validate the findings of Maas et al. [12] who suggested that preoperative ADMA levels independently predict adverse events after non-cardiac surgery. Apparently, NO bioavailability and oxidative stress are linked, and the correlation between ADMA and 8-iso-PGF 2α , which seems to confirm the existence of such links, did not escape our attention. This finding is consistent with the results of a study by Antoniades et al. [23] who demonstrated the association of ADMA levels with vascular superoxide production.
Alterations in plasma ADMA and 8-iso-PGF 2α observed after CABG could be, at least in part, explained by enhanced inflammation and ROS formation after surgery. Based on the current evidence, ROS formation and oxidative stress could be in part a consequence of hypothermia, anaesthesia, surgical trauma, manipulation of the heart, pericardial suction, heparin and protamine administration, or reperfusion of hibernated myocardium [7] . Oxidative stress, which is the highest immediately after operation, can reduce the activity of DDAH, leading to ADMA accumulation [6, 8] . Increased ADMA concentration leads to NO synthase inhibition and blockage of NO synthesis. Decreased venous endothelial production of NO reduces vascular compliance, increases vascular resistance and enhances the propensity to thrombosis. These states may facilitate graft and coronary thrombosis, leading to PMI.
In contrast to our results, Karu et al. [13] observed a significant decrease of arterial ADMA concentrations by the first post-CABG morning. It is possible that the discrepancy results from different patient characteristics, type one statistical error, and most importantly, different biological material used for ADMA assessment (i.e. arterial and coronary sinus blood vs venous blood in our study) [13] .
Furthermore, there was no correlation between postoperative ADMA or 8-iso-PGF 2α and aortic cross-clamp time. Karu et al. [13] showed that ADMA correlated with aortic cross-clamp time only in hyperoxia pretreated patients, and just in coronary sinus samples. It is probable that other factors also play an important role in the phenomenon of increased oxidative stress within the first 1-7 days following CABG.
In search for determinants of ADMA in CABG patients, we analysed several operative variables. The type of cardioplegia (blood vs crystalloid) did not have any effect on plasma ADMA and 8-iso-PGF 2α levels, or their changes following surgery. Kalawski et al. [24] showed that in spite of a significant increase in O 2 À production by polymorphonuclear neutrophils (PMN) incubated with plasma obtained from the coronary sinus immediately after reperfusion, there are no differences in plasma-induced stimulation of NO production by PMN between patients receiving crystalloid and blood cardioplegia. Our results support the concept that type of cardioplegia is unlikely to reduce oxidative stress associated with CABG.
The fact that EuroSCORE was not an independent predictor of perioperative death also deserves a comment. The patients were recruited 5 years ago, and for all of them EuroSCORE I was calculated. Calculated EuroSCORE I values were low (only elective CABG subjects, with no history of cardiac surgery, were eligible).
This study has several limitations. The size of the study group was limited and confined to coronary patients. No antioxidants were assessed, and all laboratory parameters were measured only at three time points. Windows of postoperative measurements were wide. A stricter measurement regimen could give lesser results variation. It is probable that measurements performed more often, particularly within the first 24 h after the surgery, could give new insight on the effect of CABG on ADMA formation and elimination. Finally, our observation was limited to the hospital stay. It would be of interest to evaluate oxidative stress, ADMA levels and clinical endpoints, within the first postoperative months. In conclusion, our findings indicate that enhanced oxidative stress is closely associated with ADMA accumulation in the perioperative period. Links between perioperative ADMA and unfavourable early post-CABG outcomes suggest that this marker determined prior to surgery could be useful in identifying subjects at risk of PMI, which might help to improve the CABG outcomes. Further studies are needed to validate this interesting concept. 
